25I-NBOMe: Difference between revisions
>Unity Replace DangerousInteractions Intro with template. Organize 'See also'. |
>BronzeManul Replaced UK legality statement with standard N-benzylphenethylamine UK legality statement formatted statement. |
||
Line 215: | Line 215: | ||
*'''Russia:''' Possession, production and sale is illegal.{{citation needed}} | *'''Russia:''' Possession, production and sale is illegal.{{citation needed}} | ||
*'''Sweden:''' 25I-NBOMe is classed as Schedule I.<ref>Läkemedelsverkets författningssamling - http://www.lakemedelsverket.se/upload/lvfs/LVFS_2013-15.pdf</ref> | *'''Sweden:''' 25I-NBOMe is classed as Schedule I.<ref>Läkemedelsverkets författningssamling - http://www.lakemedelsverket.se/upload/lvfs/LVFS_2013-15.pdf</ref> | ||
*'''United Kingdom | *'''United Kingdom''' - 25I-NBOMe is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause.<ref>United Kingdom. (2014). Misuse of Drugs Act 1971 (S.I. 2014/1106). London: The Stationery Office Limited. Retrieved July 5, 2017, from http://www.legislation.gov.uk/uksi/2014/1106/made</ref> | ||
*'''United States:''' On Nov 15, 2013, the DEA added 25I-NBOMe to Schedule I using their emergency scheduling powers, making it "temporarily" in Schedule I for 2 years.<ref>http://www.justice.gov/dea/divisions/hq/2013/hq111513.shtml</ref> | *'''United States:''' On Nov 15, 2013, the DEA added 25I-NBOMe to Schedule I using their emergency scheduling powers, making it "temporarily" in Schedule I for 2 years.<ref>http://www.justice.gov/dea/divisions/hq/2013/hq111513.shtml</ref> | ||